Authors' response to letter to editor-silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis.

已完结 10 由何曼慈发布于 2026/6/17 15:55:13

DOI:10.1093/ibd/izag077
作者：Raja Atreya,?Markus F Neurath
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1093/ibd/izag077

Oxford University Press

应助信息

1天前

小丹

202606171636458766246.pdf 已采纳

1天前

Book学术机器人

2026/6/17 15:55:13 未找到该文献，机器人已退出，请等待人工下载

2026/6/17 15:55:13 Book学术AI机器人收到请求，开始寻找文献

2026/6/17 15:55:13 已向机器人发送请求

1天前

何曼慈发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Oxford University PressTargeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.